A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
2d agoen
From the article
Conditions : Clear Cell Renal Cell Carcinoma Interventions : Drug: PD-32766D (a Copper-64 [64Cu] labeled peptide); Drug: PD-32766T (an Actinium-225 [225Ac] labeled peptide) Sponsors : PeptiDream Inc. Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Development of LRRC15-binding disulfide-constrained peptides for PET imaging of cancer-associated fibroblasts
doi.org·22h ago
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
GSK·17y ago
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Nature Communications·8d ago
Anixa Biosciences Aktie: Höchste Lira-cel-Dosis erreicht
aktiencheck.de
Untitled
doi.org·22d ago
Experimental Novartis radiopharma drug shows promise in early study
reuters.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.